
The Israeli military has said that Iran’s weapons production capabilities will be largely destroyed "within a few days."
Over the coming days, the military aims to "complete their attacks on all key components of the [Iranian] military industry," army spokesman Effie Defrin told journalists on Saturday evening.
"This means that we will have destroyed most military production capabilities," he added.
"It will take the regime a long time to rebuild them."
Since Israel and the US began to attack Iran four weeks ago, the Israeli Air Force has been carrying out heavy strikes on Iran's military industry.
The Israeli military estimates that it has already struck around 90% of the key facilities in the Iranian arms industry, according to the Times of Israel.
Israeli fighter jets also bombed military production facilities in Iran overnight, including the headquarters of the Marine Industries Organization which is responsible for the development and construction of warships and submarines.
LATEST POSTS
- 1
Watch SpaceX launch powerful ocean-mapping satellite for Europe and NASA early Nov. 17 - 2
Scientists detect X-ray glow from interstellar comet 3I/ATLAS extending 250,000 miles into space - 3
Baby takes 1st steps after receiving groundbreaking gene-edited therapy - 4
What exactly is the Upside Down in 'Stranger Things'? The wormhole revelation, explained. - 5
Step by step instructions to Advance the Eco-friendliness of Your Kona SUV
Nigeria’s return to Windsor castle signals new era in UK economic partnership
Finding Your Motivation: Moves toward a Satisfying Life
In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
Forget 'Outer Banks.' These Gen Z-ers just want to watch 'M*A*S*H*' and 'Gilmore Girls.'
Finding the Force of Mentorship: Self-awareness Through Direction
Hezbollah claims right to respond to killing of top commander
The Best Web-based Courses for Expertise Improvement
Yes, NASA's launching Artemis 2 astronauts to the moon on April Fools' Day. It's not a joke.
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug












